We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ACTIV-2

News List

NIH trial to evaluate antibody therapy for Covid-19 treatment pharmaceutical-technology
April 23, 2021
The National Institutes of Health (NIH) has commenced subject enrolment in a Phase II/III ACTIV-2 trial of a new fully human polyclonal antibody therapeutic called SAB-185 for treating Covid-19 in non-hospitalised individuals with mild or moderate ...
Synairgen’s inhaled COVID-19 treatment included in US trial pharmatimes
February 25, 2021
Synairgen’s inhaled interferon beta-1a treatment, SNG001, has been selected for inclusion in the US government-funded ACTIV-2 trial in COVID-19 outpatients.
eTrueNorth Recruiting COVID-Positive Individuals for ACTIV-2 Clinical Trial prnewswire
December 15, 2020
eTrueNorth, the U.S.-based healthcare technology company that enables laboratory testing at retail pharmacies and enables all surge drive-through COVID-19 specimen collection sites, will begin proactively communicating with COVID-19 positive ...